2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Non-small Cell Carcinoma: new trials by email Literature Review of Non-small Cell Carcinoma trials Research Report on Non-small Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors vobramitamab duocarmazine 2.0 mg (Arm A), vobramitamab duocarmazine 2.7 mg (Arm B), vobramitamab duocarmazine - Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer | Phase 2 | Terminated | MacroGenics | 192 | 2023-06-13 | 2026-02-09 |
| Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer Induction Durvalumab, Chemotherapy, Radiation - Lung Cancer, Non-small Cell Carcinoma | Phase 2 | Terminated | Rachel Sanborn | 10 | 2020-06-18 | 2024-12-20 |
Anus Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Small Cell (1) · Lung Neoplasms (1) · Melanoma (1) · Prostatic Neoplasms, Castration-Resistant (1) · Small Cell Lung Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Anus Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1)
Carboplatin (1) · Cisplatin (1) · Drug Therapy (1) · Etoposide (1) · Pemetrexed (1) · Radiation (1) · abiraterone (1) · durvalumab (1) · enzalutamide (1) · taxane (1)
MacroGenics (1) · Rachel Sanborn (1)
United States (2) · Australia (1) · Belgium (1) · France (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Liudmila Schafer, M.D. (1) · Rachel Sanborn, MD (1)